R.H. Dinel Investment Counsel, Inc. Exact Sciences Corp Transaction History
R.H. Dinel Investment Counsel, Inc.
- $152 Million
- Q1 2024
A detailed history of R.H. Dinel Investment Counsel, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, R.H. Dinel Investment Counsel, Inc. holds 25,700 shares of EXAS stock, worth $1.11 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
25,700
Previous 25,700
-0.0%
Holding current value
$1.11 Million
Previous $1.9 Million
6.68%
% of portfolio
1.16%
Previous 1.33%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
699Shares Held
160MCall Options Held
5.84MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$766 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$563 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$535 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$491 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$461 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.64B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...